Chlorpromazine belongs to the phenothiazine class of antipsychotic agents that act primarily as dopamine receptor antagonists. It is prescribed to manage symptoms of schizophrenia and other psychotic conditions by reducing hallucinations and delusional thinking. The drug blocks d2 receptors in the brain thereby decreasing dopaminergic neurotransmission. This blockade leads to altered activity in mesolimbic pathways that regulate mood and perception. The drug produces sedation and reduces agitation through antagonism of histamine and serotonergic receptors. The overall outcome is stabilization of psychotic symptoms and improved functional capacity for affected individuals.

Chlorpromazine is a phenothiazine derivative classified as an antipsychotic medication. It is employed clinically to manage symptoms of schizophrenia and other psychotic disturbances. The drug exerts its therapeutic effect by antagonizing dopamine d2 receptors in the brain. This receptor blockade reduces dopaminergic activity leading to decreased hallucinations and delusions. In addition it blocks histamine and serotonin receptors contributing to its sedative and antiemetic actions. The combined modulation of these neurotransmitter pathways produces a calming influence that helps stabilize mood and behavior. Overall Chlorpromazine enhances patient functioning by diminishing psychotic symptoms through sustained receptor antagonism.

Chlorpromazine may cause drowsiness in some patients. It can lead to dry mouth as a frequent complaint. Some individuals experience dizziness upon standing. Weight gain is reported by a noticeable portion of users. Skin rashes or photosensitivity can occur in certain cases. Low blood pressure may be observed especially after the first dose. A metallic taste in the mouth is occasionally noted. Fluctuations in blood cell counts are rarely but sometimes reported.

Chlorpromazine may cause drowsiness and fatigue. Some patients experience dryness of the mouth and throat. Weight gain can occur with prolonged use. Low blood pressure is a possible cardiovascular effect. Blurred vision and constipation are frequently reported. Some individuals develop extrapyramidal symptoms such as muscle stiffness. Skin rashes and sensitivity to sunlight may appear. Rarely, changes in heart rhythm have been observed.